HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.

AbstractOBJECTIVES:
The diagnosis of inclusion body myositis (IBM) can be challenging as it can be difficult to clinically distinguish from other forms of myositis, particularly polymyositis (PM). Recent studies have shown frequent presence of autoantibodies directed against cytosolic 5'-nucleotidase 1A (cN-1A) in patients with IBM. We therefore, examined the autoantigenicity and disease specificity of major epitopes of cN-1A in patients with sporadic IBM compared with healthy and disease controls.
METHODS:
Serum samples obtained from patients with IBM (n=238), PM and dermatomyositis (DM) (n=185), other autoimmune diseases (n=246), other neuromuscular diseases (n=93) and healthy controls (n=35) were analysed for the presence of autoantibodies using immunodominant cN-1A peptide ELISAs.
RESULTS:
Autoantibodies directed against major epitopes of cN-1A were frequent in patients with IBM (37%) but not in PM, DM or non-autoimmune neuromuscular diseases (<5%). Anti-cN-1A reactivity was also observed in some other autoimmune diseases, particularly Sjögren's syndrome (SjS; 36%) and systemic lupus erythematosus (SLE; 20%).
CONCLUSIONS:
In summary, we found frequent anti-cN-1A autoantibodies in sera from patients with IBM. Heterogeneity in reactivity with the three immunodominant epitopes indicates that serological assays should not be limited to a distinct epitope region. The similar reactivities observed for SjS and SLE demonstrate the need to further investigate whether distinct IBM-specific epitopes exist.
AuthorsMegan K Herbert, Judith Stammen-Vogelzangs, Marcel M Verbeek, Anke Rietveld, Ingrid E Lundberg, Hector Chinoy, Janine A Lamb, Robert G Cooper, Mark Roberts, Umesh A Badrising, Jan L De Bleecker, Pedro M Machado, Michael G Hanna, Lenka Plestilova, Jiri Vencovsky, Baziel G van Engelen, Ger J M Pruijn
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 75 Issue 4 Pg. 696-701 (Apr 2016) ISSN: 1468-2060 [Electronic] England
PMID25714931 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightPublished by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Chemical References
  • Autoantibodies
  • 5'-Nucleotidase
  • NT5C1A protein, human
Topics
  • 5'-Nucleotidase (immunology)
  • Adult
  • Aged
  • Arthritis, Rheumatoid (immunology)
  • Autoantibodies (immunology)
  • Autoimmune Diseases (immunology)
  • Case-Control Studies
  • Dermatomyositis (diagnosis, immunology)
  • Diabetes Mellitus, Type 1 (immunology)
  • Female
  • Humans
  • Lupus Erythematosus, Systemic (immunology)
  • Male
  • Middle Aged
  • Multiple Sclerosis (immunology)
  • Myositis, Inclusion Body (diagnosis, immunology)
  • Neuromuscular Diseases (immunology)
  • Polymyositis (diagnosis, immunology)
  • ROC Curve
  • Scleroderma, Systemic (immunology)
  • Sensitivity and Specificity
  • Sjogren's Syndrome (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: